A compound that helps grow new vasculature into poorly perfused tissue is, at least in theory, aimed squarely at the root of the issue
Sikiric, P., Kokot, A., Kralj, T., Zlatar, M., Masnec, S., Lazi, R., Lonari, K., Oroz, K., Sabli, M., Boljesic, M., Antunovi, M., Sikiri, S., trbe, S., Stambolija, V., Orekovi, B., Kavelj, I., Novosel, L., Zubcic, S., Krezic, I., krti, A., Jurjevi, I., Blagai, B., Seiwerth, S., & Stareini, M
The compatibility classification from our patient protocol guides is moderate and sequential only, which means it is used as a standalone cellular reset cycle, not as part of a multi-peptide stack running simultaneously
Two months is not
Contact Regenerative Orthopedic Solutions in Thousand Oaks today and take the first step toward a future free from pain
doi: 10.1128/mbio.01108-25